| Product Code: ETC7181768 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Fiji Oncology NGS Market Overview |
3.1 Fiji Country Macro Economic Indicators |
3.2 Fiji Oncology NGS Market Revenues & Volume, 2021 & 2031F |
3.3 Fiji Oncology NGS Market - Industry Life Cycle |
3.4 Fiji Oncology NGS Market - Porter's Five Forces |
3.5 Fiji Oncology NGS Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Fiji Oncology NGS Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Fiji Oncology NGS Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.8 Fiji Oncology NGS Market Revenues & Volume Share, By Workflow, 2021 & 2031F |
3.9 Fiji Oncology NGS Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 Fiji Oncology NGS Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Fiji |
4.2.2 Growing adoption of Next-Generation Sequencing (NGS) technology in oncology |
4.2.3 Government initiatives to improve healthcare infrastructure and services |
4.3 Market Restraints |
4.3.1 High cost associated with NGS technology and tests |
4.3.2 Limited awareness and access to advanced oncology diagnostics in Fiji |
5 Fiji Oncology NGS Market Trends |
6 Fiji Oncology NGS Market, By Types |
6.1 Fiji Oncology NGS Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Fiji Oncology NGS Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 Fiji Oncology NGS Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Fiji Oncology NGS Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.2 Fiji Oncology NGS Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Fiji Oncology NGS Market Revenues & Volume, By Diagnostics and Screening, 2021- 2031F |
6.2.3 Fiji Oncology NGS Market Revenues & Volume, By Research Studies, 2021- 2031F |
6.3 Fiji Oncology NGS Market, By Service |
6.3.1 Overview and Analysis |
6.3.2 Fiji Oncology NGS Market Revenues & Volume, By Platforms and Related Products, 2021- 2031F |
6.3.3 Fiji Oncology NGS Market Revenues & Volume, By Services, 2021- 2031F |
6.4 Fiji Oncology NGS Market, By Workflow |
6.4.1 Overview and Analysis |
6.4.2 Fiji Oncology NGS Market Revenues & Volume, By Pre-Sequencing, 2021- 2031F |
6.4.3 Fiji Oncology NGS Market Revenues & Volume, By Sequencing, 2021- 2031F |
6.4.4 Fiji Oncology NGS Market Revenues & Volume, By NGS Data Analysis, 2021- 2031F |
6.5 Fiji Oncology NGS Market, By End-use |
6.5.1 Overview and Analysis |
6.5.2 Fiji Oncology NGS Market Revenues & Volume, By Academic Research, 2021- 2031F |
6.5.3 Fiji Oncology NGS Market Revenues & Volume, By Clinical Research, 2021- 2031F |
6.5.4 Fiji Oncology NGS Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F |
6.5.5 Fiji Oncology NGS Market Revenues & Volume, By Pharma & Biotech Entities, 2021- 2031F |
6.5.6 Fiji Oncology NGS Market Revenues & Volume, By Other users, 2021- 2031F |
7 Fiji Oncology NGS Market Import-Export Trade Statistics |
7.1 Fiji Oncology NGS Market Export to Major Countries |
7.2 Fiji Oncology NGS Market Imports from Major Countries |
8 Fiji Oncology NGS Market Key Performance Indicators |
8.1 Average turnaround time for NGS test results in Fiji |
8.2 Number of oncology centers offering NGS testing services |
8.3 Percentage of oncologists trained in NGS technology in Fiji |
9 Fiji Oncology NGS Market - Opportunity Assessment |
9.1 Fiji Oncology NGS Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Fiji Oncology NGS Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Fiji Oncology NGS Market Opportunity Assessment, By Service, 2021 & 2031F |
9.4 Fiji Oncology NGS Market Opportunity Assessment, By Workflow, 2021 & 2031F |
9.5 Fiji Oncology NGS Market Opportunity Assessment, By End-use, 2021 & 2031F |
10 Fiji Oncology NGS Market - Competitive Landscape |
10.1 Fiji Oncology NGS Market Revenue Share, By Companies, 2024 |
10.2 Fiji Oncology NGS Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here